LINCOLN PHARMACEUTICALS
Back to Income Statement
|
LINCOLN PHARMACEUTICALS Last 5 Year Revenue History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Net Sales | ₹581 Cr | ₹510 Cr | ₹472 Cr | ₹424 Cr | ₹386 Cr |
What is the latest Revenue of LINCOLN PHARMACEUTICALS ?
| Year | Revenue |
|---|---|
| Mar2025 | ₹581 Cr |
| Mar2024 | ₹510 Cr |
| Mar2023 | ₹472 Cr |
| Mar2022 | ₹424 Cr |
| Mar2021 | ₹386 Cr |
How is Revenue of LINCOLN PHARMACEUTICALS Trending?
| Years | Revenue | % Change | |
|---|---|---|---|
| Mar2025 | ₹581 Cr | 13.76 | |
| Mar2024 | ₹510 Cr | 8.09 | |
| Mar2023 | ₹472 Cr | 11.30 | |
| Mar2022 | ₹424 Cr | 9.75 | |
| Mar2021 | ₹386 Cr | - | |
Compare Revenue of peers of LINCOLN PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| LINCOLN PHARMACEUTICALS | ₹1,221.7 Cr | 2.4% | -4.2% | 8.5% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹406,603.0 Cr | -5.6% | -2.5% | -1.7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹155,485.0 Cr | -2.6% | -8.7% | 1.2% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹135,009.0 Cr | -7.2% | -8% | 27.6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹101,628.0 Cr | -6.5% | -5.4% | 3.9% | Stock Analytics | |
| CIPLA | ₹96,400.8 Cr | -4.1% | -11.5% | -19% | Stock Analytics | |
LINCOLN PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| LINCOLN PHARMACEUTICALS | 2.4% |
-4.2% |
8.5% |
| SENSEX | -1% |
-10.9% |
-6% |
You may also like the below Video Courses